Literature DB >> 34236621

A Precision Medicine Framework for Classifying Patients with Disorders of Consciousness: Advanced Classification of Consciousness Endotypes (ACCESS).

Daniel Kondziella1,2, David K Menon3, Raimund Helbok4, Lionel Naccache5,6, Marwan H Othman7, Verena Rass4, Benjamin Rohaut8,9,10, Michael N Diringer11, Robert D Stevens12.   

Abstract

BACKGROUND: Consciousness in patients with brain injury is traditionally assessed based on semiological evaluation at the bedside. This classification is limited because of low granularity, ill-defined and rigid nomenclatures incompatible with the highly fluctuating nature of consciousness, failure to identify specific brain states like cognitive motor dissociation, and neglect for underlying biological mechanisms. Here, the authors present a pragmatic framework based on consciousness endotypes that combines clinical phenomenology with all essential physiological and biological data, emphasizing recovery trajectories, therapeutic potentials and clinical feasibility.
METHODS: The Neurocritical Care Society's Curing Coma Campaign identified an international group of experts who convened in a series of online meetings between May and November 2020 to discuss and propose a novel framework for classifying consciousness.
RESULTS: The expert group proposes Advanced Classification of Consciousness Endotypes (ACCESS), a tiered multidimensional framework reflecting increasing complexity and an aspiration to consider emerging and future approaches. Tier 1 is based on clinical phenotypes and structural imaging. Tier 2 adds functional measures including EEG, PET and functional MRI, that can be summarized using the Arousal, Volition, Cognition and Mechanisms (AVCM) score (where "Volition" signifies volitional motor responses). Finally, Tier 3 reflects dynamic changes over time with a (theoretically infinite) number of physiologically distinct states to outline consciousness recovery and identify opportunities for therapeutic interventions.
CONCLUSIONS: Whereas Tiers 1 and 2 propose an approach for low-resource settings and state-of-the-art expertise at leading academic centers, respectively, Tier 3 is a visionary multidimensional consciousness paradigm driven by continuous incorporation of new knowledge while addressing the Curing Coma Campaign's aspirational goals.

Entities:  

Keywords:  Brain injury; Coma; Consciousness; Electroencephalography; Endotypes; Functional magnetic resonance imaging; Neuroimaging

Mesh:

Year:  2021        PMID: 34236621     DOI: 10.1007/s12028-021-01246-9

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  49 in total

1.  Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome.

Authors:  Steven Laureys; Gastone G Celesia; Francois Cohadon; Jan Lavrijsen; José León-Carrión; Walter G Sannita; Leon Sazbon; Erich Schmutzhard; Klaus R von Wild; Adam Zeman; Giuliano Dolce
Journal:  BMC Med       Date:  2010-11-01       Impact factor: 8.775

2.  Comparison of the Full Outline of UnResponsiveness and Glasgow Liege Scale/Glasgow Coma Scale in an intensive care unit population.

Authors:  Marie-Aurélie Bruno; Didier Ledoux; Bernard Lambermont; François Damas; Caroline Schnakers; Audrey Vanhaudenhuyse; Olivia Gosseries; Steven Laureys
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 3.  From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness.

Authors:  Marie-Aurélie Bruno; Audrey Vanhaudenhuyse; Aurore Thibaut; Gustave Moonen; Steven Laureys
Journal:  J Neurol       Date:  2011-06-16       Impact factor: 4.849

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  Validation of a new coma scale: The FOUR score.

Authors:  Eelco F M Wijdicks; William R Bamlet; Boby V Maramattom; Edward M Manno; Robyn L McClelland
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

6.  The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility.

Authors:  Joseph T Giacino; Kathleen Kalmar; John Whyte
Journal:  Arch Phys Med Rehabil       Date:  2004-12       Impact factor: 3.966

Review 7.  The minimally conscious state: definition and diagnostic criteria.

Authors:  Joseph T Giacino; S Ashwal; N Childs; R Cranford; B Jennett; D I Katz; J P Kelly; J H Rosenberg; J Whyte; R D Zafonte; N D Zasler
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

8.  The Full Outline of UnResponsiveness (FOUR) Score and Its Use in Outcome Prediction: A Scoping Systematic Review of the Adult Literature.

Authors:  A Almojuela; M Hasen; F A Zeiler
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

Review 9.  The Glasgow Coma Scale at 40 years: standing the test of time.

Authors:  Graham Teasdale; Andrew Maas; Fiona Lecky; Geoffrey Manley; Nino Stocchetti; Gordon Murray
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

Review 10.  Minimally conscious state or cortically mediated state?

Authors:  Lionel Naccache
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

View more
  8 in total

Review 1.  Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.

Authors:  Rui-Zhe Zheng; Zeng-Xin Qi; Zhe Wang; Ze-Yu Xu; Xue-Hai Wu; Ying Mao
Journal:  Neurosci Bull       Date:  2022-07-08       Impact factor: 5.203

Review 2.  Understanding, detecting, and stimulating consciousness recovery in the ICU.

Authors:  Daniel Kondziella; Moshgan Amiri; Marwan H Othman; Elisabeth Waldemar Jakobsen; Tejs Jansen; Kirsten Møller
Journal:  Acta Neurochir (Wien)       Date:  2022-10-15       Impact factor: 2.816

Review 3.  Neuroprognostication: a conceptual framework.

Authors:  Brian L Edlow; Joseph T Giacino; David M Greer; David Fischer
Journal:  Nat Rev Neurol       Date:  2022-03-29       Impact factor: 44.711

Review 4.  Endotypes and the Path to Precision in Moderate and Severe Traumatic Brain Injury.

Authors:  Tej D Azad; Pavan P Shah; Han B Kim; Robert D Stevens
Journal:  Neurocrit Care       Date:  2022-03-21       Impact factor: 3.532

5.  Coma Science: The Territory and the Map.

Authors:  Robert D Stevens; Michael N Diringer
Journal:  Neurocrit Care       Date:  2021-07-08       Impact factor: 3.210

Review 6.  Consciousness as a multidimensional phenomenon: implications for the assessment of disorders of consciousness.

Authors:  Jasmine Walter
Journal:  Neurosci Conscious       Date:  2021-12-30

7.  Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.

Authors:  Shraddha Mainali; Venkatesh Aiyagari; Sheila Alexander; Yelena Bodien; Varina Boerwinkle; Melanie Boly; Emery Brown; Jeremy Brown; Jan Claassen; Brian L Edlow; Ericka L Fink; Joseph J Fins; Brandon Foreman; Jennifer Frontera; Romergryko G Geocadin; Joseph Giacino; Emily J Gilmore; Olivia Gosseries; Flora Hammond; Raimund Helbok; J Claude Hemphill; Karen Hirsch; Keri Kim; Steven Laureys; Ariane Lewis; Geoffrey Ling; Sarah L Livesay; Victoria McCredie; Molly McNett; David Menon; Erika Molteni; DaiWai Olson; Kristine O'Phelan; Soojin Park; Len Polizzotto; Jose Javier Provencio; Louis Puybasset; Chethan P Venkatasubba Rao; Courtney Robertson; Benjamin Rohaut; Michael Rubin; Tarek Sharshar; Lori Shutter; Gisele Sampaio Silva; Wade Smith; Robert D Stevens; Aurore Thibaut; Paul Vespa; Amy K Wagner; Wendy C Ziai; Elizabeth Zink; Jose I Suarez
Journal:  Neurocrit Care       Date:  2022-05-10       Impact factor: 3.532

8.  The Curing Coma Campaign International Survey on Coma Epidemiology, Evaluation, and Therapy (COME TOGETHER).

Authors:  Raimund Helbok; Verena Rass; Ettore Beghi; Yelena G Bodien; Giuseppe Citerio; Joseph T Giacino; Daniel Kondziella; Stephan A Mayer; David Menon; Tarek Sharshar; Robert D Stevens; Hanno Ulmer; Chethan P Venkatasubba Rao; Paul Vespa; Molly McNett; Jennifer Frontera
Journal:  Neurocrit Care       Date:  2022-02-09       Impact factor: 3.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.